The characteristics and clinical application of the ArcCHECK diode array for volumetric-modulated arc therapy verification
LI Cheng-qiang, LI Guang-jun, JI Chuan-xian, XIAO Jiang-hong, GUO Chang, QUAN Hong, BAI Sen.School of Physics and Technology, Wuhan University,Wuhan 430072,ChinaCorresponding author:BAI Sen, Radiation Physics Center, Cancer Center, West China Hospital, Sichuan University, Chengdu 610064,China;Email:Tonybaisen@yahoo.com.cn
TonybaBAI Sen.School of Physics and Technology, Wuhan University,Wuhan 430072,ChinaCorresponding author:BAI Sen, Radiation Physics Center, Cancer Center, West China Hospital, Sichuan University, Chengdu 610064,
Objective To evaluate the characteristics and clinical suitability of the ArcCHECK diode array for volumetric-modulated arc therapy (VMAT) verification. Methods The intrinsic sensitivity, short and long term reproducibility, dose and dose rate dependence, dose per pulsed dependence, field sizes dependence and directional response of the diodes were measured. The results of the diodes were compared with the measurement results of an ionization chamber and calculated results of treatment planning system. Gamma index was used to analyze the dose difference between the calculation and measurement for random selected 211 verified VMAT plans. Results The ArcCHECK performed well for all tests except directional dependence, which varies from a minimum of －3.9%(seen only when the beam was incident on the diode at 180°) to a maximum of 7.7%(approximately at 255°). Average gamma analysis passing rates with 3 mm/3% for 113 nasopharyngeal cancer, 48 cervical cancer and 50 rectal cancer patients VMAT plans were 93.5%,95.7% and 97.5%, respectively,statistical significance has been found between either two of the groups (t=－12.69—－4.88,all P<0.01). Conclusions With proposed calibration method, the ArcCHECK diode array is very suitable for VMAT pretreatment verification,the complexity of VMAT plan is the main factor affecting the passing rate.
. The characteristics and clinical application of the ArcCHECK diode array for volumetric-modulated arc therapy verification[J]. Chinese Journal of Radiation Oncology, 2013, 22(3): 253-257.
[1] Otto K. Volumetric modulated arc therapy:IMRT in a single gantry arc. Med Phys,2008,35:310-317. [2] Bortfeldand T, Webb S. Single-Arc IMRT? Phys Med Biol,2009,54:19-20. [3] Wang C, Luan S, Tang G, et al. Arc-modulated radiation therapy (AMRT):a single-arc form of intensity-modulated arc therapy. Phys Med Biol,2008,53:6291-6303. [4] Bedford JL, Warrington AP. Commissioning of volumetric modulated ARC therapy (VMAT). Int J Radiat Oncol Biol Phys,2009,73:537-545. [5] Ling CC, Zhang P, Archambault Y, et al. Commissioning and quality assurance of RAPIDARC radiotherapy delivery system. Int J Radiat Oncol Biol Phys,2008,72:575-581. [6] Low DA, Moran JM, Dempsey JF, et al. Dosimetry tools and techniques for IMRT. Med Phys,2011,38:1313-1338. [7] Rikner G, Grusell E. General specifications for silicon semiconductors for use in radiation dosimetry. Phys Med Biol,1987,32:1109-1117. [8] Robar JL, Clark BG. The use of radiographic film for linear accelerator stereotactic radiosurgical dosimetry. Med Phys,1999,26:2144-2150. [9] Yeo IJ, Beiki-Ardakani A, Cho YB, et al. EDR2 film dosimetry for IMRT verification using low-energy photon filters. Med Phys,2004,31:1960-1963. [10] Jursinic PA, Nelms BE.A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery. Med Phys,2003,30:870-879. [11] Létourneau D, Gulam M, Yan D, et al. Evaluation of a 2D diode array for IMRT quality assurance. Radiother Oncol,2004,70:199-206. [12] Li JG, Yan G, Liu C. Comparison of two commercial detector arrays for IMRT quality assurance. J Appl Clin Med Phys,2009,10:2942. [13] Saminathan S, Manickan R, Chandraraj V,et al. Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification. J Appl Clin Med Phys,2010,11:3076. [14] Spezi E, Angelini AL, Romani F,et al. Characterization of a 2D ion chamber array for the verification of radiotherapy treatments. Phys Med Biol,2005,50:3361-3373. [15] Sadagopan R, Bencomo JA, Martin RL, et al. Characterization and clinical evaluation of a novel IMRT quality assurance system. J Appl Clin Med Phys,2009,10:2928. [16] Feygelman V, Zhang G, Stevens C,et al. Evaluation of a new VMAT QA device, or the"X" and"O" array geometries. J Appl Clin Med Phys,2011,12:3346. [17] Feygelman V, Forster K, Opp D, et al. Evaluation of a biplanar diode array dosimeter for quality assurance of step-and-shoot IMRT. J Appl Clin Med Phys,2009,10:3080. [18] Bedford JL, Lee YK, Wai P, et al. Evaluation of the Delta(4) phantom for IMRT and VMAT verification. Phys Med Biol,2009,54:167-176. [19] Létourneau D, Publicover J, Kozelka J,et al. Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy. Med Phys,2009,36:1813-1821. [20] Li G, Zhang Y, Jiang X, et al. Evaluation of the ArcCHECK QA system for IMRT and VMAT verification. Phys Med,2012,In press. [21] Yan G, Lu B, Kozelka J,et al. Calibration of a novel four-dimensional diode array. Med Phys,2010,37:108-115. [22] Kozelka J, Robinson J, Nelms B, et al. Optimizing the accuracy of a helical diode array dosimeter:a comprehensive calibration methodology coupled with a novel virtual inclinometer. Med Phys,2011,38:5021-5032. [23] Both S, Alecu IM, Stan AR, et al. A study to establish reasonable action limits for patient specific quality assurance in intensity-modulated radiation therapy. J Appl Clin Med Phys,2007,8:1-8.
2013, Vol. 22 
